{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T04:47:55Z","timestamp":1785041275475,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Gastric cancer (GC) is a highly aggressive malignancy with a poor prognosis. Transfer RNA-derived small RNAs (tsRNAs) are implicated in tumorigenesis, but their precise mechanistic roles in GC progression remain incompletely understood. We performed high-throughput sequencing in four paired GC\/normal tissues to profile tsRNAs. The functional and mechanistic role of a candidate tsRNA was systematically investigated, alongside a suite of techniques including fluorescence in situ hybridization, RNA immunoprecipitation, RNA pull-down, chromatin immunoprecipitation, and luciferase reporter assays. We identified a novel tsRNA, tRF-Ser, that was significantly downregulated in GC tissues and cell lines, and its expression was correlated with favorable survival. Functionally, tRF-Ser acted as a tumor suppressor by inhibiting epithelial-mesenchymal transition (EMT), inducing ferroptosis, and enhancing sensitivity to 5-fluorouracil chemotherapy. Mechanistically, tRF-Ser directly bound to the cellular nucleic acid-binding protein CNBP (a transcription factor), promoting its accumulation in the cytoplasm and preventing its binding to the HSPA8 promoter to downregulate HSPA8. Then, the tRF-Ser\/CNBP\/HSPA8 axis suppressed EMT by inhibiting \u03b2-catenin nuclear translocation and promoted ferroptosis by facilitating STUB1-mediated ubiquitination degradation of GPX4. Our study unveils that the tRF-Ser\/CNBP\/HSPA8 axis may constrain GC progression by regulating energy metabolism, which highlights the therapeutic potential of targeting this axis for GC treatment.<\/jats:p>","DOI":"10.1038\/s41419-026-08608-1","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T23:07:04Z","timestamp":1774480024000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A new candidate tumor suppressor tRF-Ser inhibits gastric cancer progression by regulating the CNBP\/HSPA8 axis"],"prefix":"10.1038","volume":"17","author":[{"given":"Jian","family":"Jiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangchuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daocong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshu","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8553-8428","authenticated-orcid":false,"given":"Huaiping","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2329-6791","authenticated-orcid":false,"given":"Leping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"8608_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635\u201348.","journal-title":"Lancet"},{"key":"8608_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103841","volume":"181","author":"MJ L\u00f3pez","year":"2023","unstructured":"L\u00f3pez MJ, Carbajal J, Alfaro AL, Saravia LG, Zanabria D, Araujo JM, et al. Characteristics of gastric cancer around the world. Crit Rev Oncol\/Hematol. 2023;181:103841.","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"8608_CR3","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s11864-022-01004-9","volume":"23","author":"C Fong","year":"2022","unstructured":"Fong C, Johnston E, Starling N. Neoadjuvant and Adjuvant Therapy Approaches to Gastric Cancer. Curr Treat Options Oncol. 2022;23:1247\u201368.","journal-title":"Curr Treat Options Oncol"},{"key":"8608_CR4","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s12032-023-02138-y","volume":"40","author":"S Kannampuzha","year":"2023","unstructured":"Kannampuzha S, Gopalakrishnan AV. Cancer chemoresistance and its mechanisms: Associated molecular factors and its regulatory role. Med Oncol. 2023;40:264.","journal-title":"Med Oncol"},{"key":"8608_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.856974","volume":"12","author":"T Saha","year":"2022","unstructured":"Saha T, Lukong KE. Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance. Front Oncol. 2022;12:856974.","journal-title":"Front Oncol"},{"key":"8608_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.omtn.2020.05.011","volume":"21","author":"M Wang","year":"2020","unstructured":"Wang M, Yu F, Chen X, Li P, Wang K. The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma. Mol Ther Nucleic Acids. 2020;21:13\u201327.","journal-title":"Mol Ther Nucleic Acids"},{"key":"8608_CR7","doi-asserted-by":"crossref","unstructured":"Adhikari S, Bhattacharya A, Adhikary S, Singh V, Gadad SS, Roy S, et al. The paradigm of drug resistance in cancer: an epigenetic perspective. Biosci Rep. 2022;42.","DOI":"10.1042\/BSR20211812"},{"key":"8608_CR8","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41419-023-06250-9","volume":"14","author":"L Zhang","year":"2023","unstructured":"Zhang L, Liu J, Hou Y. Classification, function, and advances in tsRNA in non-neoplastic diseases. Cell Death Dis. 2023;14:748.","journal-title":"Cell Death Dis"},{"key":"8608_CR9","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1073\/pnas.1206761110","volume":"110","author":"RL Maute","year":"2013","unstructured":"Maute RL, Schneider C, Sumazin P, Holmes A, Califano A, Basso K, et al. tRNA-derived microRNA modulates proliferation and the DNA damage response and is down-regulated in B cell lymphoma. Proc Natl Acad Sci USA 2013;110:1404\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8608_CR10","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.3748\/wjg.v29.i30.4642","volume":"29","author":"XR Fan","year":"2023","unstructured":"Fan XR, Huang Y, Su Y, Chen SJ, Zhang YL, Huang WK, et al. Exploring the regulatory mechanism of tRNA-derived fragments 36 in acute pancreatitis based on small RNA sequencing and experiments. World J Gastroenterol. 2023;29:4642\u201356.","journal-title":"World J Gastroenterol"},{"key":"8608_CR11","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1016\/j.celrep.2019.11.062","volume":"29","author":"HK Kim","year":"2019","unstructured":"Kim HK, Xu J, Chu K, Park H, Jang H, Li P, et al. A tRNA-Derived Small RNA Regulates Ribosomal Protein S28 Protein Levels after Translation Initiation in Humans and Mice. Cell Rep. 2019;29:3816\u201324.e4.","journal-title":"Cell Rep"},{"key":"8608_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01992-2","volume":"23","author":"M Zhou","year":"2024","unstructured":"Zhou M, He X, Zhang J, Mei C, Zhong B, Ou C. tRNA-derived small RNAs in human cancers: roles, mechanisms, and clinical application. Mol cancer. 2024;23:76.","journal-title":"Mol cancer"},{"key":"8608_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1184615","volume":"13","author":"L Gan","year":"2023","unstructured":"Gan L, Song H, Ding X. Transfer RNA-derived small RNAs (tsRNAs) in gastric cancer. Front Oncol. 2023;13:1184615.","journal-title":"Front Oncol"},{"key":"8608_CR14","doi-asserted-by":"publisher","first-page":"8740","DOI":"10.1002\/jcp.27533","volume":"234","author":"Y Cui","year":"2019","unstructured":"Cui Y, Huang Y, Wu X, Zheng M, Xia Y, Fu Z, et al. Hypoxia-induced tRNA-derived fragments, novel regulatory factor for doxorubicin resistance in triple-negative breast cancer. J Cell Physiol. 2019;234:8740\u201351.","journal-title":"J Cell Physiol"},{"key":"8608_CR15","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41419-022-04930-6","volume":"13","author":"H Cui","year":"2022","unstructured":"Cui H, Li H, Wu H, Du F, Xie X, Zeng S, et al. A novel 3\u2019tRNA-derived fragment tRF-Val promotes proliferation and inhibits apoptosis by targeting EEF1A1 in gastric cancer. Cell Death Dis. 2022;13:471.","journal-title":"Cell Death Dis"},{"key":"8608_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/carcin\/bgae010","volume":"45","author":"Y Shi","year":"2024","unstructured":"Shi Y, Pan Z, Feng Y, Zhou Q, Wang Q, Wang H, et al. tRF-29-79 regulates lung adenocarcinoma progression through mediating glutamine transporter SLC1A5. Carcinogenesis. 2024;45:409\u201323.","journal-title":"Carcinogenesis"},{"key":"8608_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu X, Jin S, Chen Y, Guo R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol cancer. 2022;21:47.","journal-title":"Mol cancer"},{"key":"8608_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8608_CR19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22:381\u201396.","journal-title":"Nat Rev Cancer"},{"key":"8608_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520:57\u201362.","journal-title":"Nature"},{"key":"8608_CR21","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018;20:1181\u201392.","journal-title":"Nat Cell Biol"},{"key":"8608_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03391-5","volume":"24","author":"S Wang","year":"2024","unstructured":"Wang S, Wang R, Hu D, Zhang C, Cao P, Huang J, et al. Epigallocatechin gallate modulates ferroptosis through downregulation of tsRNA-13502 in non-small cell lung cancer. Cancer Cell Int. 2024;24:200.","journal-title":"Cancer Cell Int"},{"key":"8608_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/biof.2124","volume":"51","author":"Y Huang","year":"2025","unstructured":"Huang Y, Zhang R, Fan S, Shi M, Tang X, Wang X, et al. OSBPL10-CNBP axis mediates hypoxia-induced pancreatic cancer development. BioFactors. 2025;51:e2124.","journal-title":"BioFactors"},{"key":"8608_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-024-00506-w","volume":"19","author":"X Liu","year":"2024","unstructured":"Liu X, Chen Y, Li Y, Bai J, Zeng Z, Wang M, et al. STAU1-mediated CNBP mRNA degradation by LINC00665 alters stem cell characteristics in ovarian cancer. Biol Direct. 2024;19:59.","journal-title":"Biol Direct"},{"key":"8608_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1235","volume":"13","author":"A Hu","year":"2023","unstructured":"Hu A, Chen G, Bao B, Guo Y, Li D, Wang X, et al. Therapeutic targeting of CNBP phase separation inhibits ribosome biogenesis and neuroblastoma progression via modulating SWI\/SNF complex activity. Clin Transl Med. 2023;13:e1235.","journal-title":"Clin Transl Med"},{"key":"8608_CR26","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1158\/0008-5472.CAN-22-3169","volume":"83","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhao M, Zhao L, Geng Y, Li G, Chen L, et al. HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression. Cancer Res. 2023;83:1048\u201361.","journal-title":"Cancer Res"},{"key":"8608_CR27","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1038\/s44319-024-00112-x","volume":"25","author":"S Gan","year":"2024","unstructured":"Gan S, Zhou S, Ma J, Xiong M, Xiong W, Fan X, et al. BAG5 regulates HSPA8-mediated protein folding required for sperm head-tail coupling apparatus assembly. EMBO Rep. 2024;25:2045\u201370.","journal-title":"EMBO Rep"},{"key":"8608_CR28","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1080\/15548627.2023.2223468","volume":"19","author":"C Miao","year":"2023","unstructured":"Miao C, Zhang Y, Yu M, Wei Y, Dong C, Pei G, et al. HSPA8 regulates anti-bacterial autophagy through liquid-liquid phase separation. Autophagy. 2023;19:2702\u201318.","journal-title":"Autophagy"},{"key":"8608_CR29","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41422-023-00859-3","volume":"33","author":"E Wu","year":"2023","unstructured":"Wu E, He W, Wu C, Chen Z, Zhou S, Wu X, et al. HSPA8 acts as an amyloidase to suppress necroptosis by inhibiting and reversing functional amyloid formation. Cell Res. 2023;33:851\u201366.","journal-title":"Cell Res"},{"key":"8608_CR30","doi-asserted-by":"crossref","unstructured":"Armas P, Coux G, Weiner AMJ, Calcaterra NB. What\u2019s new about CNBP? Divergent functions and activities for a conserved nucleic acid binding protein. Biochim Biophys Acta Gen Subj. 2021;1865:129996.","DOI":"10.1016\/j.bbagen.2021.129996"},{"key":"8608_CR31","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/mc.23030","volume":"58","author":"E Lee","year":"2019","unstructured":"Lee E, Lee TA, Yoo HJ, Lee S, Park B. CNBP controls tumor cell biology by regulating tumor-promoting gene expression. Mol Carcinogen. 2019;58:1492\u2013501.","journal-title":"Mol Carcinogen"},{"key":"8608_CR32","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1093\/nar\/gkx071","volume":"45","author":"E Lee","year":"2017","unstructured":"Lee E, Lee TA, Kim JH, Park A, Ra EA, Kang S, et al. CNBP acts as a key transcriptional regulator of sustained expression of interleukin-6. Nucleic acids Res. 2017;45:3280\u201396.","journal-title":"Nucleic acids Res"},{"key":"8608_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2025.167827","volume":"1871","author":"A Ruzza","year":"2025","unstructured":"Ruzza A, Zaltron E, Vianello F, Celotti I, Scavezzon M, Severin F, et al. HSPA8 and HSPA9: Two prognostic and therapeutic targets in breast, colon, and kidney cancers? Biochim Biophys Acta Mol Basis Dis. 2025;1871:167827.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"8608_CR34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13046-025-03460-1","volume":"44","author":"D Cai","year":"2025","unstructured":"Cai D, Chen X, Xu H, Zhao Q, Zhou X, Wu J, et al. m5C-modified circRREB1 promotes lung cancer progression by inducing mitophagy. J Exp Clin Cancer Res. 2025;44:203.","journal-title":"J Exp Clin Cancer Res"},{"key":"8608_CR35","first-page":"356","volume":"56","author":"X Kou","year":"2024","unstructured":"Kou X, Yang X, Zhao Z, Li L. HSPA8-mediated stability of the CLPP protein regulates mitochondrial autophagy in cisplatin-resistant ovarian cancer cells. Acta Biochim Biophys Sin. 2024;56:356\u201365.","journal-title":"Acta Biochim Biophys Sin"},{"key":"8608_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103270","volume":"75","author":"K Zeng","year":"2024","unstructured":"Zeng K, Huang N, Liu N, Deng X, Mu Y, Zhang X, et al. LACTB suppresses liver cancer progression through regulation of ferroptosis. Redox Biol. 2024;75:103270.","journal-title":"Redox Biol"},{"key":"8608_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2024.119684","volume":"1871","author":"Y Tao","year":"2024","unstructured":"Tao Y, Lu J, Li L, Lu L, Fu B, Zhang J, et al. Raltitrexed induces apoptosis through activating ROS-mediated ER stress by impeding HSPA8 expression in prostate cancer cells. Biochim Biophys Acta Mol Cell Res. 2024;1871:119684.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"8608_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02162-0","volume":"23","author":"C Zeng","year":"2024","unstructured":"Zeng C, Nie D, Wang X, Zhong S, Zeng X, Liu X, et al. Combined targeting of GPX4 and BCR-ABL tyrosine kinase selectively compromises BCR-ABL+\u2009leukemia stem cells. Mol Cancer. 2024;23:240.","journal-title":"Mol Cancer"},{"key":"8608_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306535","volume":"11","author":"B Li","year":"2024","unstructured":"Li B, Ming H, Qin S, Zhou L, Huang Z, Jin P, et al. HSPA8 Activates Wnt\/\u03b2-Catenin Signaling to Facilitate BRAF V600E Colorectal Cancer Progression by CMA-Mediated CAV1 Degradation. Adv Sci. 2024;11:e2306535.","journal-title":"Adv Sci"},{"key":"8608_CR40","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41419-023-06300-2","volume":"14","author":"X Sun","year":"2023","unstructured":"Sun X, Zhang Q, Lin X, Shu P, Gao X, Shen K. Imatinib induces ferroptosis in gastrointestinal stromal tumors by promoting STUB1-mediated GPX4 ubiquitination. Cell Death Dis. 2023;14:839.","journal-title":"Cell Death Dis"},{"key":"8608_CR41","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang S, Li H, Zhang L, Mu W, Zhang Y, Chen T, et al. Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res. 2025;53:D1670\u2013d6.","journal-title":"Nucleic Acids Res"},{"key":"8608_CR42","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1631\/jzus.B2300215","volume":"25","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Gu X, Li Y, Li X, Huang Y, Ju S. Transfer RNA-derived fragment tRF-23-Q99P9P9NDD promotes progression of gastric cancer by targeting ACADSB. J Zhejiang Univ Sci B. 2024;25:438\u201350.","journal-title":"J Zhejiang Univ Sci B"},{"key":"8608_CR43","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.7150\/ijbs.87415","volume":"20","author":"Y He","year":"2024","unstructured":"He Y, Liu Y, Gong J, Yang F, Sun C, Yan X, et al. tRF-27 competitively Binds to G3BPs and Activates MTORC1 to Enhance HER2 Positive Breast Cancer Trastuzumab Tolerance. Int J Biol Sci. 2024;20:3923\u201341.","journal-title":"Int J Biol Sci"},{"key":"8608_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang H, Deng T, Liu R, Ning T, Yang H, Liu D, et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer. 2020;19:43.","journal-title":"Mol Cancer"},{"key":"8608_CR45","doi-asserted-by":"publisher","first-page":"115711","DOI":"10.1016\/j.biopha.2023.115711","volume":"168","author":"M Zhao","year":"2023","unstructured":"Zhao M, Lu T, Bi G, Hu Z, Liang J, Bian Y, et al. PLK1 regulates chemoradiotherapy sensitivity of esophageal squamous cell carcinoma through pentose phosphate pathway\/ferroptosis. Biomed Pharmacother. 2023;168:115711.","journal-title":"Biomed Pharmacother"},{"key":"8608_CR46","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1158\/0008-5472.CAN-16-1979","volume":"77","author":"S Zhu","year":"2017","unstructured":"Zhu S, Zhang Q, Sun X, Zeh HJ 3rd, Lotze MT, et al. HSPA5 Regulates Ferroptotic Cell Death In Cancer Cells. Cancer Res. 2017;77:2064\u201377.","journal-title":"Cancer Res"},{"key":"8608_CR47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.tig.2018.10.006","volume":"35","author":"M Trabucchi","year":"2019","unstructured":"Trabucchi M, Mategot R. Subcellular Heterogeneity of the microRNA Machinery. Trends Genet: TIG. 2019;35:15\u201328.","journal-title":"Trends Genet: TIG"},{"key":"8608_CR48","doi-asserted-by":"crossref","unstructured":"Jie M, Feng T, Huang W, Zhang M, Feng Y, Jiang H, et al. Subcellular localization of miRNAs and implications in cellular homeostasis. Genes. 2021;12.","DOI":"10.3390\/genes12060856"},{"key":"8608_CR49","doi-asserted-by":"publisher","first-page":"7901","DOI":"10.1093\/nar\/gkz527","volume":"47","author":"AP David","year":"2019","unstructured":"David AP, Pipier A, Pascutti F, Binolfi A, Weiner AMJ, Challier E, et al. CNBP controls transcription by unfolding DNA G-quadruplex structures. Nucleic Acids Res. 2019;47:7901\u201313.","journal-title":"Nucleic Acids Res"},{"key":"8608_CR50","doi-asserted-by":"crossref","unstructured":"Chen Y, Lei X, Jiang Z, Fitzgerald KA Cellular nucleic acid-binding protein is essential for type I interferon-mediated immunity to RNA virus infection. Proc Natl Acad Sci USA 2021;118.","DOI":"10.1073\/pnas.2100383118"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08608-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08608-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08608-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T21:01:53Z","timestamp":1774990913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08608-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8608"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08608-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was reviewed and approved by the Ethics Committee of Shandong Provincial Hospital Affiliated to Shandong First Medical University (No. 2025-280). All animal experiments were reviewed and approved by the Animal Experiment Ethics Committee of Shandong First Medical University (No. LS2024050).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"379"}}